Skip to main content
. 2023 Jul 28;131(7):077010. doi: 10.1289/EHP12215

Table 5.

Associations of air pollutants with risk of all-cause mortality in individuals with IBD, CD, and UC in the UK Biobank study, mean follow-up of 12 y.

Air pollutants in quartiles (μg/m3) IBD (n=4,708) CD (n=1,485) UC (n=3,233)
Cases/person-years HR (95% CI)a p-Value HR (95% CI)b p-Valuec Cases/person-years HR (95% CI)b p-Value Cases/person-years HR (95% CI)b p-Value
NOx
 Per IQR (15.6) 1.12 (1.03, 1.21) 0.008 1.10 (1.01, 1.20) 0.036 1.04 (0.89, 1.21) 0.637 1.14 (1.01, 1.29) 0.030
 Q1 (19.7 to<34.8) 82/13,835 Ref Ref 28/4,425 Ref 54/9,360 Ref
 Q2 (34.8 to<42.0) 118/13,701 1.51 (1.14, 2.01) 0.004 1.44 (1.08, 1.91) 0.012 41/4,165 1.57 (0.96, 2.54) 0.070 77/9,510 1.37 (0.97, 1.95) 0.076
 Q3 (42.0 to<50.4) 114/13,580 1.49 (1.12, 1.98) 0.006 1.39 (1.04, 1.85) 0.026 39/4,422 1.33 (0.82, 2.18) 0.250 75/9,013 1.41 (0.99, 2.01) 0.058
 Q4 (50.4–247.5) 106/13,788 1.53 (1.15, 2.04) 0.004 1.39 (1.04, 1.86) 0.025 36/4,178 1.30 (0.79, 2.14) 0.301 70/9,489 1.37 (0.95, 1.96) 0.088
p-Trend 0.007 0.049 0.481 0.106
NO2
 Per IQR (10.4) 1.18 (1.06, 1.31) 0.003 1.16 (1.03, 1.29) 0.010 1.17 (0.98, 1.41) 0.079 1.13 (0.98, 1.30) 0.091
 Q1 (10.0 to<23.0) 92/13,825 Ref Ref 32/4,521 Ref 60/9,269 Ref
 Q2 (23.0 to<27.9) 110/13,765 1.26 (0.95, 1.66) 0.107 1.21 (0.92, 1.60) 0.178 38/4,149 1.29 (0.80, 2.07) 0.290 72/9,494 1.19 (0.84, 1.68) 0.319
 Q3 (27.9 to<33.4) 98/13,822 1.13 (0.85, 1.50) 0.405 1.05 (0.79, 1.39) 0.755 29/4,360 0.91 (0.55, 1.51) 0.709 69/9,356 1.10 (0.77, 1.56) 0.592
 Q4 (33.4–86.6) 120/13,491 1.58 (1.20, 2.07) 0.001 1.48 (1.13, 1.95) 0.005 45/4,161 1.55 (0.98, 2.46) 0.059 75/9,254 1.42 (1.01, 2.00) 0.045
p-Trend 0.004 0.018 0.162 0.079
PM10
 Per IQR (2.3) 1.04 (1.01, 1.06) 0.003 1.15 (1.03, 1.30) 0.015 1.26 (1.04, 1.53) 0.017 1.08 (0.93, 1.26) 0.299
 Q1 (13.7 to<18.0) 93/13,810 Ref Ref 26/4,245 Ref 67/9,493 Ref
 Q2 (18.0 to<19.1) 95/13,906 1.03 (0.77, 1.37) 0.854 1.01 (0.76, 1.34) 0.946 35/4,546 1.34 (0.80, 2.23) 0.263 60/9,278 0.87 (0.62, 1.24) 0.451
 Q3 (19.1 to<20.3) 121/13,715 1.39 (1.06, 1.82) 0.017 1.35 (1.03, 1.76) 0.032 39/4,270 1.60 (0.97, 2.65) 0.067 82/9,331 1.18 (0.85, 1.64) 0.317
 Q4 (20.3–28.6) 111/13,472 1.38 (1.05, 1.82) 0.022 1.34 (1.02, 1.77) 0.037 44/4,130 1.84 (1.13, 3.01) 0.015 67/9,272 1.12 (0.80, 1.57) 0.511
P-Trend 0.004 0.008 0.011 0.237
PM2.5
 Per IQR (1.3) 1.02 (1.01, 1.03) 0.003 1.14 (1.02, 1.28) 0.019 1.10 (0.91, 1.33) 0.325 1.17 (1.01, 1.36) 0.030
 Q1 (8.2 to<9.3) 86/13,865 Ref Ref 33/4,508 Ref 53/9,284 Ref
 Q2 (9.3 to<9.9) 120/13,605 1.43 (1.09, 1.89) 0.011 1.38 (1.04, 1.82) 0.023 41/4,280 1.33 (0.84, 2.12) 0.223 79/9,289 1.40 (0.99, 1.98) 0.059
 Q3 (9.9 to<10.6) 102/13,650 1.25 (0.94, 1.67) 0.125 1.16 (0.87, 1.55) 0.307 32/4,161 1.05 (0.64, 1.71) 0.858 70/9,389 1.22 (0.85, 1.76) 0.272
 Q4 (10.6–20.7) 112/13,783 1.46 (1.10, 1.94) 0.008 1.36 (1.02, 1.80) 0.035 38/4,242 1.24 (0.77, 1.98) 0.377 74/9,411 1.40 (0.98, 2.00) 0.062
p-Trend 0.031 0.118 0.613 0.140

Note: —, no data; BMI, body mass index; CD, Crohn’s disease; CI, confidence interval; HR, hazard ratio; IBD, inflammatory bowel disease; IQR, interquartile range; NO2, nitrogen dioxide; NOx, nitrogen oxides; PM, particulate matter; PM2.5 PM with aerodynamic diameter 2.5μm; PM10, PM with aerodynamic diameter 10μm; Ref, reference; UC, ulcerative colitis.

a

Based on Cox proportional model adjusted for age, sex, ethnicity.

b

Based on Cox proportional model adjusted for age, sex, ethnicity, assessment centers, household income, smoking status, education, BMI, physical activity, healthy diet, alcohol consumption, baseline related surgery history, medication (use of nonsteroidal anti-inflammatory drugs, amino salicylates, corticosteroids, and immunomodulators).

c

p-Value <0.05 was considered statistically significant.